Literature DB >> 10723064

Down-regulation of mu-opioid receptor expression in rat oligodendrocytes during their development in vitro.

P Tryoen-Toth1, C Gavériaux-Ruff, G Labourdette.   

Abstract

In the central nervous system, opioid receptors are found in neurons and also in glial cells. To gain more information on their presence and possibly on their function, we investigated the expression of mu-opioid receptors (MOR) during oligodendroglial cell development in two culture systems. In these models, during the first days, the cells are O-2A bipotential progenitor cells (also called OPCs; oligodendrocyte precursor cells), and then they differentiate into oligodendrocytes, which mature. In the first system, oligodendroglial cells, derived from newborn rat brain hemispheres, are grown in primary culture in the presence of a confluent layer of astrocytes, and they differentiate slowly. In the second, cells are specifically detached from the mixed cultures of the first system and are grown thereafter alone in secondary culture, a condition allowing a rapid cell differentiation. Under both conditions OPCs and immature oligodendrocytes were found to express a high level of MOR mRNA, whereas mature oligodendrocytes did not express it at all. The decrease of MOR expression during oligodendrocyte maturation was progressive, suggesting that it was not a primary effect of differentiation but an indirect secondary effect. Our study also shows that basic fibroblast growth factor (bFGF), which has been claimed by some authors to induce a dedifferentiation of the mature oligodendrocytes, and retinoic acid (RA), which had not been tested before, were not able to restore MOR expression in mature oligodendrocytes. These results indicate that bFGF and RA neither reverse the maturation process nor dedifferentiate the cells. However, RA was found to inhibit almost completely the expression of the myelin basic protein. The main result of this study is that MOR is expressed in progenitors and in immature oligodendrocytes, but not in mature oligodendrocytes. This suggests that MOR could be involved in some developmental process of the cells of the oligodendroglial lineage. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10723064     DOI: 10.1002/(SICI)1097-4547(20000401)60:1<10::AID-JNR2>3.0.CO;2-O

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  13 in total

1.  Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy.

Authors:  Andrew C Eschenroeder; Allison A Vestal-Laborde; Emilse S Sanchez; Susan E Robinson; Carmen Sato-Bigbee
Journal:  Glia       Date:  2011-10-14       Impact factor: 7.452

Review 2.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

Review 3.  Opioids, gliosis and central immunomodulation.

Authors:  Salim Kadhim; John McDonald; David G Lambert
Journal:  J Anesth       Date:  2018-07-27       Impact factor: 2.078

4.  Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: impact on gliogenesis in vivo.

Authors:  A Stiene-Martin; P E Knapp; K Martin; J A Gurwell; S Ryan; S R Thornton; F L Smith; K F Hauser
Journal:  Glia       Date:  2001-10       Impact factor: 7.452

5.  Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro.

Authors:  S K Buch; V K Khurdayan; S E Lutz; P E Knapp; N El-Hage; K F Hauser
Journal:  Neuroscience       Date:  2007-05-02       Impact factor: 3.590

6.  Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain.

Authors:  Emilse S Sanchez; John W Bigbee; Wambura Fobbs; Susan E Robinson; Carmen Sato-Bigbee
Journal:  Glia       Date:  2008-07       Impact factor: 7.452

7.  Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity.

Authors:  Jianren Mao; Backil Sung; Ru-Rong Ji; Grewo Lim
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

8.  Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro.

Authors:  Valeriya K Khurdayan; Shreya Buch; Nazira El-Hage; Sarah E Lutz; Susan M Goebel; Indrapal N Singh; Pamela E Knapp; Jadwiga Turchan-Cholewo; Avindra Nath; Kurt F Hauser
Journal:  Eur J Neurosci       Date:  2004-06       Impact factor: 3.386

9.  HIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology.

Authors:  Kurt F Hauser; Yun Kyung Hahn; Valeriya V Adjan; Shiping Zou; Shreya K Buch; Avindra Nath; Annadora J Bruce-Keller; Pamela E Knapp
Journal:  Glia       Date:  2009-01-15       Impact factor: 7.452

Review 10.  Opiate drug use and the pathophysiology of neuroAIDS.

Authors:  Kurt F Hauser; Sylvia Fitting; Seth M Dever; Elizabeth M Podhaizer; Pamela E Knapp
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.